Protection from tumor development by prophylactic IL-13Rα2 DNA vaccination boosted with ECDα2 protein in MCA304 sarcoma, 4T1 breast carcinoma, and D5α2 melanoma models. This evidence concerns the gene IL13RA2 and neoplasm.